Akinobu Maeda Selected Research

LDL Lipoproteins (beta Lipoproteins)

4/2013

Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akinobu Maeda Research Topics

Disease

14	Hypertension (High Blood Pressure) 05/2015 - 11/2009
7	Chronic Renal Insufficiency 01/2014 - 01/2011
4	Hypertrophy 03/2017 - 05/2010
4	Abdominal Obesity 03/2017 - 01/2013
3	Obesity 03/2017 - 01/2013
3	Body Weight (Weight, Body) 01/2014 - 01/2013
2	Fibrosis (Cirrhosis) 07/2017 - 10/2011
2	Insulin Resistance 03/2017 - 01/2012
2	Inflammation (Inflammations) 03/2017 - 10/2011
2	Albuminuria 01/2014 - 07/2013
2	Cardiomegaly (Heart Hypertrophy) 08/2013 - 05/2010
2	Proteinuria 03/2013 - 11/2009
1	Ureteral Obstruction 06/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2013
1	Peripheral Arterial Disease 04/2013
1	Atherosclerosis 04/2013
1	Dyslipidemias (Dyslipidemia) 04/2013
1	Essential Hypertension 08/2012
1	Disease Progression 01/2012
1	Eosinophilia 01/2012
1	Hypertriglyceridemia 01/2012
1	Starvation 07/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2011
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2010
1	AIDS-Related Complex (ARC) 07/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2009
1	Prostatic Neoplasms (Prostate Cancer) 09/2006
1	Genomic Instability 09/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2017 - 05/2010
7	Angiotensin IIIBA 03/2017 - 05/2010
5	Type 1 Angiotensin ReceptorIBA 03/2017 - 05/2010
4	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 01/2011
3	AlbuminsIBA 01/2014 - 01/2011
3	olmesartanIBA 01/2014 - 10/2011
3	Therapeutic UsesIBA 01/2014 - 10/2011
3	CreatinineIBA 01/2014 - 01/2011
3	aliskiren FDA Link 07/2013 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 01/2011
2	AldosteroneIBA 09/2014 - 07/2013
2	SodiumIBA 09/2014 - 06/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 01/2014 - 01/2012
2	Angiotensin Receptor AntagonistsIBA 01/2014 - 07/2013
2	ReninIBA 08/2013 - 07/2010
2	AngiotensinsIBA 08/2013 - 06/2013
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 07/2013 - 06/2013
2	Messenger RNA (mRNA)IBA 06/2013 - 07/2011
2	Angiotensin II Type 1 Receptor BlockersIBA 03/2013 - 11/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	AdipokinesIBA 03/2017
1	bofu-tsusho-sanIBA 05/2015
1	Sodium-Hydrogen ExchangersIBA 09/2014
1	AngiotensinogenIBA 09/2014
1	Irbesartan FDA LinkGeneric 01/2014
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2013
1	N-Type Calcium Channels (N-Type Calcium Channel)IBA 08/2013
1	cilnidipineIBA 08/2013
1	Carrier Proteins (Binding Protein)IBA 07/2013
1	benazepril (Briem)FDA LinkGeneric 07/2013
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Epithelial Sodium ChannelsIBA 06/2013
1	oxidized low density lipoproteinIBA 04/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2013
1	calcium phosphateIBA 04/2013
1	azilsartanIBA 02/2013
1	LDL CholesterolIBA 01/2013
1	candesartanIBA 01/2012
1	SaltsIBA 10/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2011
1	Collagen Type I (Type I Collagen)IBA 10/2011
1	Fibronectins (Fibronectin)IBA 10/2011
1	Fluvastatin FDA Link 01/2011
1	Valsartan (Vals)FDA Link 01/2011
1	p38 Mitogen-Activated Protein KinasesIBA 05/2010
1	Losartan (Cozaar)FDA LinkGeneric 11/2009
1	Telmisartan (Micardis)FDA Link 11/2009
1	AndrogensIBA 09/2006
1	Androgen Receptors (Androgen Receptor)IBA 09/2006

Therapy/Procedure

6	Therapeutics 05/2015 - 01/2011
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2017
1	Blood Component Removal (Apheresis) 04/2013